[go: up one dir, main page]

HK1185264A - Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor - Google Patents

Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor Download PDF

Info

Publication number
HK1185264A
HK1185264A HK13112666.3A HK13112666A HK1185264A HK 1185264 A HK1185264 A HK 1185264A HK 13112666 A HK13112666 A HK 13112666A HK 1185264 A HK1185264 A HK 1185264A
Authority
HK
Hong Kong
Prior art keywords
skin tumor
receptor agonist
preventing
adrenergic receptor
alpha
Prior art date
Application number
HK13112666.3A
Other languages
Chinese (zh)
Inventor
Guy Bouvier
Matthew James Leoni
Michael Graeber
Original Assignee
盖尔德马研究及发展公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 盖尔德马研究及发展公司 filed Critical 盖尔德马研究及发展公司
Publication of HK1185264A publication Critical patent/HK1185264A/en

Links

Abstract

Methods, compositions and products for preventing skin tumor formation or inhibiting development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an α2 adrenergic receptor agonist, such brimonidine
HK13112666.3A 2010-06-30 2011-06-29 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor HK1185264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/344,333 2010-06-30

Publications (1)

Publication Number Publication Date
HK1185264A true HK1185264A (en) 2014-02-14

Family

ID=

Similar Documents

Publication Publication Date Title
WO2012001065A3 (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
WO2012032209A3 (en) Pharmaceutical composition for the treatment of dry eye
MY171899A (en) New cyclohexylamine derivatives having ?2 adrenergic agonist and m3 muscarinic antagonist activities
SG195375A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
TN2015000244A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
IN2012DN02177A (en)
IN2012DN02702A (en)
IN2012DN00754A (en)
NZ590650A (en) Buprenorphine analogs
MX2013004491A (en) Boronates as arginase inhibitors.
BR112012027743A2 (en) cyclopropyl dicarboxamides and analogs exhibiting anticancer and antiproliferative activities
JO3078B1 (en) Morpholinothiazoles as alpha 7 positive allosteric modulators
UA102857C2 (en) Quinuclidine carbonate derivatives and use thereof
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
MX342947B (en) Treatment of type 2 diabetes.
WO2015013709A3 (en) Compositions for treating skin thickening
UA103996C2 (en) Ivabradine hydrobromide
TW200800993A (en) Organic compounds
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
WO2012001064A3 (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
PL2146951T3 (en) Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
HK1185264A (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
HK1185265A (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor